HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T, not B, lymphocytes are required for immunodeficiency and paralysis induced by ts1, a mutant of Moloney murine leukemia virus-TB.

Abstract
BALB/c mice when injected as newborn with ts1, a temperature-sensitive mutant of Moloney murine leukemia virus-TB, developed a fatal hindlimb paralysis and immunodeficiency. This disease induction was prevented, to a great extent, by transient depletion of the peripheral T lymphocytes during the early course of infection by using anti-Thy 1.2 antibody. FVB/N mice, which are highly susceptible to ts1, but express Thy 1.1 instead of Thy 1.2 on their T lymphocytes, did not show any difference in the disease profile when treated similarly with anti-Thy 1.2 antibody. Transient depletion of the peripheral B lymphocytes in BALB/c mice in the early course of ts1 infection had no effect on the disease induction. In the T cell depleted BALB/c mice, virus replication was reduced, survival of the mice was increased and viral specific antibodies were produced, whereas, in the B cell depleted mice the disease process went on in a fashion similar to untreated mice infected with ts1. Thus, this study demonstrates that the disease syndrome induced by ts1 in BALB/c mice is dependent upon the presence of T lymphocytes during the early course of infection, and that presence of B lymphocytes have little or no effect on the disease outcome.
AuthorsK Saha, P K Wong
JournalVirology (Virology) Vol. 183 Issue 2 Pg. 815-20 (Aug 1991) ISSN: 0042-6822 [Print] United States
PMID1853579 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Animals
  • B-Lymphocytes (immunology)
  • Fluorescent Antibody Technique
  • Mice
  • Mice, Inbred BALB C
  • Moloney murine leukemia virus (genetics)
  • Murine Acquired Immunodeficiency Syndrome (immunology, microbiology)
  • Mutation
  • T-Lymphocytes (immunology)
  • Virus Replication (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: